EHA: European Hematology Association

Conference Coverage

Approach can reduce drug-induced TLS

Photo courtesy of EHA MILAN—The BCL-2 inhibitor ABT-199 may be a feasible treatment option for patients with chronic lymphocyctic leukemia/small...

Pages